These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 34865146

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
    Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM.
    Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
    Gold A, Fichtner A, Choukair D, Schmitt CP, Süsal C, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Mar; 36(3):725-729. PubMed ID: 33355703
    [Abstract] [Full Text] [Related]

  • 26. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation.
    Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH.
    Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, Zabińska M, Myszka M, Kamińska M, Hałoń A, Dawiskiba T, Szyber P, Sas A, Klinger M.
    Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
    [Abstract] [Full Text] [Related]

  • 30. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward.
    Pearl MH.
    Pediatr Transplant; 2024 May; 28(3):e14762. PubMed ID: 38650537
    [Abstract] [Full Text] [Related]

  • 31. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH.
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
    Son BS, Lee HJ, Cho WH, So MW, Park JM, Yeo HJ.
    Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
    [Abstract] [Full Text] [Related]

  • 34. Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.
    Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Duong Van Huyen JP, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.
    J Am Soc Nephrol; 2019 Apr; 30(4):692-709. PubMed ID: 30850439
    [Abstract] [Full Text] [Related]

  • 35. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
    Philogene MC, Zhou S, Lonze BE, Bagnasco S, Alasfar S, Montgomery RA, Kraus E, Jackson AM, Leffell MS, Zachary AA.
    Hum Immunol; 2018 Apr; 79(4):195-202. PubMed ID: 29428484
    [Abstract] [Full Text] [Related]

  • 36. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
    Aziz F, Jung-Hynes B, Parajuli S, Redfield RR, Astor BC, Mandelbrot D, Hidalgo L, Djamali A.
    Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review.
    Sorohan BM, Ismail G, Leca N, Tacu D, Obrișcă B, Constantinescu I, Baston C, Sinescu I.
    Transplant Rev (Orlando); 2020 Oct; 34(4):100573. PubMed ID: 33002671
    [Abstract] [Full Text] [Related]

  • 38. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies.
    Fuss A, Hope CM, Deayton S, Bennett GD, Holdsworth R, Carroll RP, Coates PT.
    Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938
    [Abstract] [Full Text] [Related]

  • 39. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
    Pizzo H, Mirocha J, Choi J, Garrison J, Haas M, Zhang X, Kamil ES, Kim I, Jordan SC, Puliyanda DP.
    Pediatr Transplant; 2022 Dec; 26(8):e14400. PubMed ID: 36168673
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
    Jalalonmuhali M, Caroll R, Deayton S, Emery T, Humphreys I, Lim SJ, Lim SK, Coates T.
    Hum Immunol; 2020 Dec; 81(12):679-684. PubMed ID: 32736900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.